EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Epigenetic regulation of tumor immunity

Lizhi Pang, Fei Zhou, Yang Liu, Heba Ali, Fatima Khan, Amy B Heimberger, Peiwen Chen

Journal of Clinical Investigation · 17.06.2024 · 134 (12)

DOI: 10.1172/jci178540 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, online erschienen am 17.06.2024. Verfasst von Lizhi Pang und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Neoplasms, Epigenesis, Genetic, Tumor Microenvironment, Immunotherapy. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although cancer has long been considered a genetic disease, increasing evidence shows that epigenetic aberrations play a crucial role in affecting tumor biology and therapeutic response. The dysregulated epigenome in cancer cells reprograms the immune landscape within the tumor microenvironment, thereby hindering antitumor immunity, promoting tumor progression, and inducing immunotherapy resistance. Targeting epigenetically mediated tumor-immune crosstalk is an emerging strategy to inhibit tumor progression and circumvent the limitations of current immunotherapies, including immune checkpoint inhibitors. In this Review, we discuss the mechanisms by which epigenetic aberrations regulate tumor-immune interactions and how epigenetically targeted therapies inhibit tumor progression and synergize with immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsEpigenesis, GeneticTumor MicroenvironmentImmunotherapyHumansAnimalsGene Expression Regulation, Neoplastic

Förderung

  • NINDS NIH HHS
  • Department of Defense

Zitieren

APA

Pang, L., Zhou, F., Liu, Y., Ali, H., Khan, F., Heimberger, A. B., & Chen, P. (2024). Epigenetic regulation of tumor immunity. Journal of Clinical Investigation, 134(12). https://doi.org/10.1172/jci178540

Vancouver

Pang L, Zhou F, Liu Y, Ali H, Khan F, Heimberger AB, et al. Epigenetic regulation of tumor immunity. Journal of Clinical Investigation. 2024;134(12). doi:10.1172/jci178540

BibTeX
@article{Pang2024,
  author = {Pang, Lizhi and Zhou, Fei and Liu, Yang and Ali, Heba and Khan, Fatima and Heimberger, Amy B and Chen, Peiwen},
  title = {Epigenetic regulation of tumor immunity},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  volume = {134},
  number = {12},
  doi = {10.1172/jci178540}
}
Kostenlos starten →